The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)
NCT05763953
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Paroxysmal Supraventricular Tachycardia
Interventions
DRUG:
Etripamil NS
Sponsor
Milestone Pharmaceuticals Inc.